206 related articles for article (PubMed ID: 3613757)
1. Effects of (D-Ala2,D-Leu5)enkephalinamide on isolated longitudinal muscle guinea pig and rat intestines.
Venkova K; Radomirov R; Petkov VD
Methods Find Exp Clin Pharmacol; 1987 May; 9(5):291-6. PubMed ID: 3613757
[TBL] [Abstract][Full Text] [Related]
2. Effects of structurally different (Leu5) enkephalinamides on electrically-evoked contractions of guinea pig ileum.
Radomirov R; Petkov VD; Venkova K
Biomed Biochim Acta; 1987; 46(5):381-5. PubMed ID: 2822036
[TBL] [Abstract][Full Text] [Related]
3. Biological tests for opiate activity of newly-synthesized compounds--opioid peptides and cyclic beta-diketones.
Petkov VD; Radomirov R; Minchev S; Petkov D; Alexiev V; Stoev S; Venkova K; Mancheva I; Stoyneva I; Petkov VV
Acta Physiol Pharmacol Bulg; 1989; 15(1):19-30. PubMed ID: 2773647
[TBL] [Abstract][Full Text] [Related]
4. Effect of [D-Ala2,Met5]enkephalinamide and [D-Ala2,D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria.
Wong-Dusting HK; Rand MJ
Eur J Pharmacol; 1985 Apr; 111(1):65-72. PubMed ID: 2990945
[TBL] [Abstract][Full Text] [Related]
5. Opiate-like peptides. Part VIII. Methylamides and dimethylamides of [D-Leu5]-enkephalin and [D-Ala2, D-Leu5]-enkephalin. Synthesis and analgesic activity.
Rolka K; Kolasa K; Kleinrok Z; Kupryszewski G
Pol J Pharmacol Pharm; 1986; 38(4):391-402. PubMed ID: 3534824
[TBL] [Abstract][Full Text] [Related]
6. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
[TBL] [Abstract][Full Text] [Related]
7. Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity.
Roubini E; Laufer R; Gilon C; Selinger Z; Roques BP; Chorev M
J Med Chem; 1991 Aug; 34(8):2430-8. PubMed ID: 1714957
[TBL] [Abstract][Full Text] [Related]
8. Preparation and opioid activities of N-methylated analogs of [D-Ala2,Leu5]enkephalin.
Kawai M; Fukuta N; Ito N; Kagami T; Butsugan Y; Maruyama M; Kudo Y
Int J Pept Protein Res; 1990 May; 35(5):452-9. PubMed ID: 2165469
[TBL] [Abstract][Full Text] [Related]
9. Binding and metabolism studies with [3H](D-Ala2,Leu5)enkephalinamide and [3H](D-Ala2,Pro5)enkephalinamide: evidence for a selective interaction of (D-Ala2,Pro5)enkephalinamide with mu-receptors.
Audigier Y; Mazarguil H; Roy J; Morgat JL; Cros J
Eur J Pharmacol; 1981 Sep; 74(4):273-8. PubMed ID: 6271558
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of N alpha-, and C alpha-derivatives of (D)Ala2, Leu5-enkephalin.
Filippi B; Biondi L; Filira F; Rocchi R
Farmaco Sci; 1983 Oct; 38(10):713-24. PubMed ID: 6641923
[TBL] [Abstract][Full Text] [Related]
11. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
12. Tolerance and cross-tolerance to the antisecretory effects of enkephalins on the guinea-pig ileal mucosa.
Vinayek R; Brown DR; Miller RJ
J Pharmacol Exp Ther; 1985 Mar; 232(3):781-5. PubMed ID: 2983070
[TBL] [Abstract][Full Text] [Related]
13. Affinity labeling of delta-opiate receptors using [D-Ala2,Leu5,Cys6]enkephalin. Covalent attachment via thiol-disulfide exchange.
Bowen WD; Hellewell SB; Kelemen M; Huey R; Stewart D
J Biol Chem; 1987 Oct; 262(28):13434-9. PubMed ID: 2820969
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the antisecretory effects of [D-Ala2,D-Leu5]enkephalin in the guinea-pig ileum by a selective delta opioid antagonist.
Vinayek R; Brown DR; Miller RJ
Eur J Pharmacol; 1983 Oct; 94(1-2):159-61. PubMed ID: 6317398
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of (D)Ala2,Leu5-enkephalins containing hydrophilic or hydrophobic moieties.
Filippi B; Biondi L; Filira F; Rocchi R; Bellini C; Sarto G
Biopolymers; 1983 Jan; 22(1):575-8. PubMed ID: 6370327
[No Abstract] [Full Text] [Related]
16. Lack of irreversible antagonism of opioid & receptors by [D-ala2,Leu5,Cys6] enkephalin in the mouse isolated vas deferens preparation.
Wild KD; Jiang Q; Iannone M; Bowen W; Porreca F
NIDA Res Monogr; 1990; 105():402-3. PubMed ID: 1652085
[No Abstract] [Full Text] [Related]
17. Adrenergic mediation of the intestinal antisecretory action of opiates administered into the central nervous system.
Brown DR; Miller RJ
J Pharmacol Exp Ther; 1984 Oct; 231(1):114-9. PubMed ID: 6387084
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis and biological activity of a lysine-containing cyclic analog of [Leu5]enkephalin].
Bobrova IV; Abissova NA; Rozental' GF; Nikiforovich GV; Chipens GI
Bioorg Khim; 1985 Nov; 11(11):1457-67. PubMed ID: 3004508
[TBL] [Abstract][Full Text] [Related]
20. [The effect of di- and trivalent metal ions on the binding of [3H-Tyr1, D-Ala2, D-Leu5] enkephalin to opiate receptors from the rat brain].
Porodenko NV; Zaĭtsev SV; Varfolomeev SD
Bioorg Khim; 1984 Jul; 10(7):902-11. PubMed ID: 6093821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
